Powered by Google Google ÜbersetzerGoogle Übersetzer
Originaltext
Diese Übersetzung bewerten
Mit deinem Feedback können wir Google Übersetzer weiter verbessern
Latest Press Releases
View all
TimeHeadline
Just nowPress Release Apr 29 2026
2m agoColgate, in partnership with Hong Kong Dental Association, launches TOTAL Periodontal Health Lab
28m agoNavios Maritime Partners L.P. Announces First Day of Trading of Bonds at Euronext Oslo Børs
29m agoAddex GABAB PAM Candidate Demonstrates Solid Anti-Tussive Activity in Bleomycin IPF-Related Chronic Cough Model
29m agoFiverr Announces First Quarter 2026 Results
Shanghai Fosun Pharmaceutical Group Co Ltd logo

Shanghai Fosun Pharmaceutical Group Co Ltd

About

Shanghai Fosun Pharmaceutical Group Co Ltd (SHG:600196) — investor relations, events, news, and company updates on 6ix.

Latest News

Dec 9 2025
Fosun Pharma's Subsidiary Yao Pharma and Pfizer Enter into Exclusive Collaboration and License Agreement
Oct 28 2025
Fosun Pharma Announces 2025Q3 Financial Results
Aug 26 2025
Fosun Pharma Announces 2025 Interim Results
Aug 12 2025
Fosun Pharma's Small Molecule Innovative Drug XH-S004 Achieves Overseas Licensing for a Potential Total of $645 Million
Jun 16 2025
Teva and Fosun Pharma Enter into a Strategic Partnership to Develop Novel Anti-PD1-IL2 Therapy (TEV-56278) in Immuno-Oncology

Financials

Revenue
CN¥41.66 B
Market Cap
CN¥71.3 B
P/E Ratio
21.02
EPS
1.27
Dividend Yield
1.44%

Community Chat

Ask AI

6ix6ixAIEvents